Meindert Boysen explains how NICE is helping to get transformative healthcare technologies to patients quicker
Patients with acute ischaemic stroke should be offered a procedure to remove the blood clot up to 24 hours after the onset of symptoms.
Women should be offered the treatment option of their choice, in discussion with their clinician
Katie Currie, public health principal, outlines how the NICE Scholar programme shaped her career development
Nageena Khalique QC, barrister and chair of the committee for the NICE guideline on Decision making and mental capacity, discusses how the new guideline applies to a range of situations
Dialysis choice allows patients to live the life they want to
Paige Ataou shares her experience of mental health in the changing world and talks about environment and relationships
Natasha Sloman, head of Hospital Inspection at the Care Quality Commission (CQC), discusses how working with NICE has been fundamental in making her work a success
Reductions to the price of three multiple sclerosis (MS) drugs mean NICE is now able to recommend them for routine NHS funding.
Victoria Hilton and her team, finalists of the NICE Shared Learning Awards, tell us about an improved care pathway to support better outcomes for patients with gastrointestinal problems
Jason tells us why winning a prestigious Skills for Care award matters to him and his team
NICE has set out its position on its complex but positive relationship with the life sciences industry.
NICE publishes first guideline on cerebral palsy
Patients’ priorities will be brought to the fore in new Alzheimer’s project
NICE and LSE Health will boost their research and educational activities aimed at informing health policy and practice across the UK.
NICE is taking part in a project that will examine how quality of life measures used to evaluate healthcare treatments such as drugs can be extended into areas of social care and public health.
NICE is launching an online tool to help medtech companies get their products to patients faster.
NICE has recommended the Intrabeam Radiotherapy System for people with early breast cancer in limited circumstances with additional data collection.
The drug, sorafenib (also known as Nexavar), which is used for treating advanced hepatocellular carcinoma, is not value for money, NICE has said in new draft guidance.
People with heart failure are set to benefit from longer-lasting battery technology in implantable heart rhythm devices, following guidance from NICE.
NICE has published diagnostics guidance recommending that everyone who is diagnosed with colorectal cancer should be tested for an inherited genetic condition called Lynch syndrome (LS).
NICE has published draft guidance saying the cost of using nivolumab to treat head and neck cancer is too high for routine NHS use.
NICE says that a drug for metastatic pancreatic cancer is not beneficial enough to justify its high cost for routine NHS use
NICE is calling on general practice staff to assess the mental health of all women who have recently given birth, as fears some may be left unsupported.
Patients will have routine access to more cancer drugs as companies have dropped their prices as part of the reformed Cancer Drugs Fund (CDF) process.
Nicola tells us why she is glad her daughter was not given antibiotics for her ear infection.
Good management of antibiotics can halve the number of people picking-up drug-resistant infections in hospital, new data suggests.
People who incorrectly believe they are allergic to penicillin are unnecessarily put at an increased risk of developing MRSA or C difficile, NICE warns today.